01 1AbbVie Corporation
02 2Allergan Inc.
03 2Gowling WLG (Canada) LLP
04 1Warner Chilcott Canada Co.
05 9Blank
01 51320727
02 41338376
03 12122479
04 32294595
05 12602188
06 12763775
01 1RISEDRONATE SODIUM
02 5Risedronate Sodium
03 9Blank
01 3Delayed Release Tablet
02 1TABLET
03 2Tablet
04 9Blank
01 42008-04-09
02 52010-07-27
03 12012-11-02
04 32018-07-17
05 12023-05-02
06 12025-11-23
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Brand Name : ACTONEL
Patent Number : 2294595
Filing Date : 1998-07-17
Strength per Unit : 35 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Brand Name : ACTONEL
Patent Number : 2294595
Filing Date : 1998-07-17
Strength per Unit : 75mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Patent Expiration Date : 2025-11-23
Date Granted : 2009-10-13
Brand Name : ACTONEL DR
Patent Number : 2602188
Filing Date : 2005-11-23
Strength per Unit : 35 mg
Dosage Form : Delayed Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-11-23
Date Granted : 2009-10-13
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Brand Name : ACTONEL DR
Patent Number : 2294595
Filing Date : 1998-07-17
Strength per Unit : 35 mg
Dosage Form : Delayed Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Patent Expiration Date : 2023-05-02
Date Granted : 2014-01-07
Brand Name : ACTONEL
Patent Number : 2763775
Filing Date : 2003-05-02
Strength per Unit : 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-05-02
Date Granted : 2014-01-07
Patent Expiration Date : 2012-11-02
Date Granted : 1998-08-25
Brand Name : ACTONEL DR
Patent Number : 2122479
Filing Date : 1992-11-02
Strength per Unit : 35 mg
Dosage Form : Delayed Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-11-02
Date Granted : 1998-08-25
Patent Expiration Date : 2008-04-09
Date Granted :
Brand Name :
Patent Number : 1338376
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2008-04-09
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2008-04-09
Date Granted :
Brand Name :
Patent Number : 1338376
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2008-04-09
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2008-04-09
Date Granted :
Brand Name :
Patent Number : 1338376
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2008-04-09
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2008-04-09
Date Granted :
Brand Name :
Patent Number : 1338376
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2008-04-09
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
